MktsMarkets

Phio Pharmaceuticals Corp.
NASDAQ: PHIOKey statistics
PHIO News
Stories mentioning PHIO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 2,793 | 1,477 | 1,181 | 1,074 | 886.00 | 985.00 | 644.00 | 866.00 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 4,167 | 2,534 | 2,505 | 2,309 | 1,872 | 1,674 | 1,590 | 1,914 |
| Operating Income (Loss) | (4,167) | (2,534) | (2,505) | (2,309) | (1,872) | (1,674) | (1,590) | (1,914) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 3.00 | 0.00 | (22.00) | 0.00 | ||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (4,003) | (2,371) | (2,392) | (2,166) | (1,769) | (1,626) | (1,524) | (1,846) |
| Earnings Per Share (Basic) | (0.34) | (0.40) | (0.44) | (0.45) | (0.41) | (2.07) | (1.54) | (3.62) |
| Earnings Per Share (Diluted) | (0.45) | (0.41) | (2.07) | (1.54) | (3.62) | |||
| Weighted Average Shares Outstanding (Basic) | 11,617 | 5,984 | 5,469 | 4,795 | 4,307 | 787.00 | 990.00 | 510.00 |
| Weighted Average Shares Outstanding (Diluted) | 4,795 | 4,307 | 787.00 | 990.00 | 510.00 | |||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PHIO
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a stock listed on the Nasdaq Stock Market under the ticker symbol PHIO. It last traded at $0.8800 (Oct 29, 2026, 10:42 AM ET), down 3.9% on the day. That gives Phio Pharmaceuticals a market capitalisation of $10.4M.
Over the past 52 weeks PHIO has traded between $0.8100 and $4.19.
For the quarter ended Mar 31, 2026 it reported a net loss of $4.0M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$4.0M |
| Dec 31, 2025 | — | -$2.4M |
| Sep 30, 2025 | — | -$2.4M |
| Jun 30, 2025 | — | -$2.2M |
From Phio Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…